David Ranson, executive chairman of FivepHusion, said, “As we pursue late clinical-stage development of our lead drug Deflexifol, augmenting and expanding the diversity and skill set of our Board is paramount to optimally positioning our company for global development activities and commercialisation." …
FivepHusion announces the appointment of experienced industry executive to its board
October 9, 2023 Australian Biotech
Latest Video
New Stories
-
New Zealand moves again to make it easier to access medicines
July 11, 2025 - - Latest News -
The 'Dispatched' Week in Review Podcast - 10 July
July 10, 2025 - - Podcast -
'The debate is frustrating but it is an opportunity to amplify acknowledged concerns'
July 10, 2025 - - Latest News -
Medibank to subsidise pharmacogenetic testing for members
July 10, 2025 - - Latest News -
Is this the missing link in pharma engagement strategies?
July 9, 2025 - - Latest News -
Stakeholders welcome medicinal cannabis crackdown
July 9, 2025 - - Latest News -
Might Australia be just a little hypocritical on pharmaceutical tariffs?
July 9, 2025 - - Latest News